News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ventria Bioscience and University of Southern California Awarded Grant to Develop a Fusion Protein for the Treatment of Diabetes


2/12/2013 9:42:33 AM

FORT COLLINS, Colo.--(BUSINESS WIRE)--The National Institutes of Health has awarded a Small Business Innovation Research (SBIR) grant to Ventria Bioscience and the University of Southern California (USC), with the goal of developing a cost-effective method for producing clinical-grade proinsulin-transferrin (ProINS-Tf) using Ventria Bioscience’s ExpressTec recombinant expression system. ProINS-Tf is a fusion protein between proinsulin and transferrin and has been shown to exhibit enhanced, sustained, hypoglycemic efficacy in vivo compared to therapeutic insulin, making it a novel candidate treatment for diabetes.

Read at BioSpace.com

comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES